Gregory Gibson
Overview
Explore the profile of Gregory Gibson including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
30
Citations
427
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Newman E, Kamanu C, Gibson G, Brailovsky Y
Curr Cardiol Rep
. 2024 Aug;
26(9):995-1003.
PMID: 39093374
Purpose Of Review: Heart failure is a clinical syndrome with signs and symptoms from underlying cardiac abnormality and evidence of pulmonary or systemic congestion on laboratory testing or other objective...
2.
Gamero M, Uber P, Brailovsky Y, Gibson G, Rame E, Alvarez R, et al.
Clin Transplant
. 2024 Mar;
38(3):e15274.
PMID: 38485673
No abstract available.
3.
Rajapreyar I, Soliman O, Brailovsky Y, Tedford R, Gibson G, Mohacsi P, et al.
JACC Heart Fail
. 2023 Jun;
11(8 Pt 1):865-878.
PMID: 37269258
Late right heart failure (RHF) is increasingly recognized in patients with long-term left ventricular assist device (LVAD) support and is associated with decreased survival and increased incidence of adverse events...
4.
Undamatla R, Fagunloye O, Chen J, Edmunds L, Murali A, Mills A, et al.
Res Sq
. 2023 Jan;
PMID: 36711642
Nonalcoholic fatty liver disease (NAFLD) encompasses a spectrum of pathologies that includes steatosis, steatohepatitis (NASH) and fibrosis and is strongly associated with insulin resistance and type 2 diabetes. Changes in...
5.
Itagaki S, Toyoda N, Egorova N, Sun E, Lee T, Boateng P, et al.
J Thorac Cardiovasc Surg
. 2022 May;
167(1):205-214.e5.
PMID: 35618532
Objectives: Although the SynCardia total artificial heart (SynCardia Systems, LLC) was approved for use as a bridge to transplantation in 2004 in the United States, most centers do not adopt...
6.
Kowalczyk A, Gbadamosi O, Kolor K, Sosa J, Andrzejczuk L, Gibson G, et al.
Biochem J
. 2021 Aug;
478(17):3205-3220.
PMID: 34397090
Recent advances in genome sequencing have led to the identification of new ion and metabolite transporters, many of which have not been characterized. Due to the variety of subcellular localizations,...
7.
Niklinska-Schirtz B, Venkateswaran S, Anbazhagan M, Kolachala V, Prince J, Dodd A, et al.
Cell Mol Gastroenterol Hepatol
. 2021 Jul;
12(4):1267-1280.
PMID: 34271224
Background & Aims: We used patient-derived organoids (PDOs) to study the epithelial-specific transcriptional and secretome signatures of the ileum during Crohn's disease (CD) with varying phenotypes to screen for disease...
8.
Chen D, Gregory A, Li X, Wei J, Burton C, Gibson G, et al.
JCI Insight
. 2021 Jun;
6(12).
PMID: 34156033
Necroptosis has emerged as a potential mechanism in the pathogenesis of chronic obstructive pulmonary disease (COPD). Here, we found that markers of necroptosis, including high mobility group box 1 release...
9.
Shook E, Curtis A, Curtis J, Gibson G, Vander Horst A, Little V, et al.
Int J Environ Res Public Health
. 2019 Mar;
16(5).
PMID: 30866474
The 2014⁻2016 Ebola Virus Disease (EVD) epidemic outbreak reached over 28,000 cases and totaled over 11,000 deaths with 4 confirmed cases in the United States, which sparked widespread public concern...
10.
DAmore A, Nasello G, Luketich S, Denisenko D, Jacobs D, Hoff R, et al.
Soft Matter
. 2018 Oct;
14(42):8483-8495.
PMID: 30357253
Physical cues are decisive factors in extracellular matrix (ECM) formation and elaboration. Their transduction across scale lengths is an inherently symbiotic phenomenon that while influencing ECM fate is also mediated...